1h Free Analyst Time
The publisher has been monitoring the anti-nuclear antibody (ANA) testing market and it is poised to grow by 362.30 million during 2021-2025, progressing at a CAGR of about 7% during the forecast period. This report on anti-nuclear antibody (ANA) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of autoimmune diseases and discovery of novel biomarkers. In addition, increasing number of autoimmune diseases is anticipated to boost the growth of the market as well.
The anti-nuclear antibody (ANA) testing market analysis includes end-user segment and geographic landscape.
The anti-nuclear antibody (ANA) testing market is segmented as below:
By End-user
- Hospitals
- Clinical diagnostic laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the advances in laboratory automation platforms as one of the prime reasons driving the anti-nuclear antibody (ANA) testing market growth during the next few years.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on anti-nuclear antibody (ANA) testing market covers the following areas:
- Anti-nuclear antibody (ANA) testing market sizing
- Anti-nuclear antibody (ANA) testing market forecast
- Anti-nuclear antibody (ANA) testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-nuclear antibody (ANA) testing market vendors that include Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the anti-nuclear antibody (ANA) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global anti-nuclear antibody (ANA) testing market: Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the advances in laboratory automation platforms.'
According to the report, one of the major drivers for this market is the increasing number of autoimmune diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Immuno Concepts Ltd.
- Merck KGaA
- PerkinElmer Inc.
- Seramun Diagnostica GmbH
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
